UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 05, 2025 08:00 ET | Source: UroGen Pharma Ltd. PRINCETON, N.J.,…
Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT for Parkinsons Disease
December 05, 2025 08:00 ET | Source: Amneal Pharmaceuticals LLC Interim data…
Renuka Iyer, MD, Named New Chief Medical Officer for National Comprehensive Cancer Network (NCCN)
Acclaimed oncologist from Roswell Park Comprehensive Cancer Center to help lead nonprofit…
Clarivate Presents Cortellis Regulatory AI Assistant to Cut Through Complexity in Safety and Compliance
Powered by agentic AI, new features help regulatory teams improve accuracy and…
McLaren Bay Region Raises the Bar on Emergency Department Communication with MEDI+SIGN
BAY CITY, Mich., Dec. 04, 2025 (GLOBE NEWSWIRE) -- McLaren Bay Region…
Oncotelic and Sapu Nano Announce DeciparticleTM Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine
AGOURA HILLS, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc.…
American Society of Clinical Oncology (ASCO) announces dates for 2026 ASCO Breakthrough and begins accepting submissions for novel oncology research
Global oncology society calls for abstract submissions for research that is shaping…
Emerald Clinical Appoints Luke Gill as Vice President, Global Head of Oncology, Medical & Scientific Affairs
Accomplished biotech and CRO leader brings 25+ years of global oncology drug…
Nika Pharmaceuticals, Inc. (NIKA) Progress Update
HENDERSON, Nev., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB:…
Carl H. Sharperson III Joins MATTER Board of Directors
December 03, 2025 10:00 ET | Source: MATTER MINNEAPOLIS, MN , Dec.…